Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 25.25 Delayed Data As of 4:00pm ET |  +2.04 / +8.79%Today’s Change | 18.47 Today|||52-Week Range 114.80 | -4.25% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Soni Manmeet Singh Chief Operating & Financial Officer |  Buy | 12/31/2021 | 16,000 | $26.22 | $419.5K | -4.13% |
Ryder Steven W Director | Gift | 7/11/2022 | 4,171 | $32.36 | $135.0K | -21.88% |
Ryder Steven W Director | Gift | 7/11/2022 | 3,794 | $32.36 | $122.8K | -21.88% |
Ryder Steven W Director | Gift | 7/11/2022 | 913 | $32.36 | $29.5K | -21.88% |
Ruff Shamim Director | Gift | 1/03/2022 | 118 | $27.32 | $3.2K | -7.47% |
Edwards Martin W Director | Gift | 1/03/2022 | 59 | $27.32 | $1.6K | -7.47% |
Mcclellan William D Jr Director | Gift | 1/03/2022 | 59 | $27.32 | $1.6K | -7.47% |
Wortley Michael D Chief Legal Officer | Gift | 1/03/2022 | 35,000 | $0.00 | $0.00 | -7.47% |
Soni Manmeet Singh Chief Operating & Financial Officer | Gift | 1/03/2022 | 50,000 | $0.00 | $0.00 | -7.47% |
Meyer Colin Chief Research Officer | Gift | 1/03/2022 | 35,000 | $0.00 | $0.00 | -7.47% |
Page of 2